Pharmaceutical Benefits Scheme

World News

Cost Breakthrough: Advanced Melanoma Treatment Subsidized for Australians

The Australian government is set to reduce the cost of advanced melanoma treatment through the Pharmaceutical Benefits Scheme (PBS). Health Minister Mark Butler announced that Opdualag, a combination of immunotherapies for recurrent or metastatic melanoma, will be subsidized for patients aged over 12. Approximately 940 patients will benefit from the PBS subsidy, with a significant reduction in treatment costs, making…